WFH eLearning Platform - Improving Care for People with VWD

Details

Year: 2021

Language: English

Author(s): World Federation of Hemophilia

Date: May 18, 2021

Also Available In: Russian, French, Spanish, Arabic

Access Webinar

Additional Information

Listen to this 90-minute webinar presented on May 18, 2021 to learn about the recently published ASH ISTH NHF WFH 2021 Guidelines on the Diagnosis and Management of von Willebrand Disease (VWD).

The session was moderated by Nathan Connell (Assistant Professor of Medicine, Harvard Medical School).

Michelle Lavin (WFH VWD & RBD Committee Chair), Baiba Ziemele (WFH Board Member and president of the Latvia Hemophilia Society Latvia) and Nicolas Giraud (President of the Association française des hémophiles) discussed specific recommendations on diagnosis and management of VWD and how they can be applied to different resource contexts. Participants also learned about recent developments related to care for people with VWD.

To download a pdf of the slides of the webinar, click the icon below.

The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.

The WFH does not promote any particular pharmaceutical product and any mention of any commercial brand in this presentation is strictly for educational purposes.

Related Resources